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Vitamin D supplementation to prevent COVID-19 in patients with 
COPD: a research perspective
To the Editor
The Coronavirus disease 2019 (COVID-19) 
is a global pandemic that has caused now more 
than 200000 deaths. Its mortality is increased in 
people with comorbidities, such as chronic obs-
tructive pulmonary disease (COPD) [1, 2]. There 
is increased evidence that the massive release 
of pro-inflammatory cytokines leading to the 
cytokine storm syndrome shapes the evolution 
of COVID-19 and is responsible of the severity of 
COVID-19 in some patients [3]. A recent review 
argued that vitamin D deficiency could have 
increased the COVID-19 outbreak and suggested 
vitamin D supplementation as a preventive action 
[4]. In fact, many factors seem to be correlated 
both to low vitamin D levels and the importance of 
COVID-19 spreading and severity. It is also impor-
tant to highlight that the lockdown, implemented 
in many countries, prevents people to go out and 
then increases the risk of vitamin D deficiency.
Vitamin D receptor is widely present in diffe-
rent tissues of the organism. Therefore, vitamin D 
is involved in multiple biological metabolisms. It 
was proven to have immunomodulatory func-
tions, and particularly suppresses pro-inflam-
matory cytokines [5]. Very few dietary sources 
are known to contain significant quantities of 
vitamin D, such as cod liver oil, oily fish and 
fortified food in some countries. This vitamin is 
mainly synthesized in the skin when exposed to 
ultra-violet (UV) radiation. Its synthesis is thus 
influenced by different factors such as the season, 
the time of the exposure during the day and the 
latitude. The zenith angle influences vitamin D 
production by modulating the path of UV radiation 
to the skin. That is why, latitude affects vitamin D 
levels, and vitamin D can hardly be produced ne-
ither above (to the north) and below (to the south) 
33° latitude during winter months, nor in the early 
morning and late afternoon (approximately before 
10 a.m. and after 3 p.m.). Vitamin D status changes 
depending on the period of the year. In fact, they 
reach their peak at the end of the summer, while 
the lowest levels are observed at the end of the 
winter. Besides, air pollution absorbs UV and so 
reduces vitamin D synthesis [6]. The facts that the 
outbreak is taking place when vitamin D levels are 
at their lowest, that the most affected countries by 
COVID-19 are northern countries and that polluted 
cities were more hit [7] suggested that it could be 
linked to sun exposure and vitamin D. Different 
factors may interfere with these variables such as 
the ability of the virus to resist to high temperatu-
res as well as the effects of air pollution on health. 
It is still early to conclude about the spreading and 
severity of the disease in southern countries which 
differ in the time of the beginning, the governmen-
tal measures, the strength of the health system, and 
possible genetic and social factors.
Vitamin D deficiency represents a common 
public health issue in many countries world-
wide. COPD patients are particularly at risk to 
have low levels of vitamin D due to multiple risk 
factors associated to the disease, such as aging, 
reduced outdoors activity, poor diet, and the use 
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of corticosteroids [8]. COPD is more than just an 
airways disease. In fact, it may generate a systemic 
inflammatory process responsible of secondary 
extra-pulmonary impairments. Although COPD 
patients share certain risk factors that may explain 
some of the comorbidities, such as smoking histo-
ry, physical inactivity and aging, other frequently 
observed comorbidities cannot be easily attributed 
to them. There is increasing evidence that COPD is 
just a part from a chronic inflammation linking the-
se comorbidities and explaining why they develop 
together [9]. Vitamin D deficiency could sustain and 
aggravate the systemic inflammation associated to 
COPD. Reports have also shown that vitamin D defi-
ciency was associated to exacerbations and hospital 
admissions, as well as lung function [5]. That may 
be explained by the immunomodulatory effects of 
vitamin D. Recent research showed that vitamin 
D supplementation significantly reduced COPD 
exacerbations [10]. These encouraging results are 
a further argument to test this option. 
Although vitamin D deficiency was not pro-
ved to be neither a risk factor of COVID-19, 
nor a determinant of its severity, it represents 
a preventive perspective that needs to be further 
studied. Future studies should precise the rela-
tion between stages of COPD and COVID-19, and 
test the effectiveness of a preventive vitamin D 
supplementation. 
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